KIRSKE DAVID (EVP, Chief Financial Officer) sold 11.1% of their position (2.11K shares) of CTI BIOPHARMA CORP on the open market
Open‑market sale worth $13.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
common stock
Shares
+1.40K
Price / share
$0.95
Trade value
$1.33K
% of position
common stock
Shares
−1.40K
Price / share
$6.25
Trade value
$8.75K
% of position
common stock
Shares
+100.00
Price / share
$0.95
Trade value
$94.89
% of position
common stock
Shares
−100.00
Price / share
$6.26
Trade value
$626.00
% of position
common stock
Shares
+609.00
Price / share
$0.95
Trade value
$577.88
% of position
common stock
Shares
−609.00
Price / share
$6.27
Trade value
$3.82K
% of position
Net shares
+0.00
Net value
-$11.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Direct | 10/4/2022 | M · Option Exercise | +1.40K | $0.95 | $1.33K | 8.3% | 16.91K | 18.31K |
| common stock Direct | 10/4/2022 | S · Sale | −1.40K | $6.25 | $8.75K | 7.6% | 18.31K | 16.91K |
| common stock Direct | 10/4/2022 | M · Option Exercise | +100.00 | $0.95 | $94.89 | 0.6% | 16.91K | 17.01K |
| common stock Direct | 10/4/2022 | S · Sale | −100.00 | $6.26 | $626.00 | 0.6% | 17.01K | 16.91K |
| common stock Direct | 10/4/2022 | M · Option Exercise | +609.00 | $0.95 | $577.88 | 3.6% | 16.91K | 17.52K |
| common stock Direct | 10/4/2022 | S · Sale | −609.00 | $6.27 | $3.82K | 3.5% | 17.52K | 16.91K |
| Total | +0.00 | -$11.19K | ||||||
Non-Qualified Stock Option (right to buy)
Common Stock
1.40K shares
Shares
−1.40K
Strike price
0.9489
Held after
324.97K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
100.00 shares
Shares
−100.00
Strike price
0.9489
Held after
324.87K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
609.00 shares
Shares
−609.00
Strike price
0.9489
Held after
324.26K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock1.40K shares | 10/4/2022 | M · Option Exercise | −1.40K | 0.9489 | — | 324.97K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock100.00 shares | 10/4/2022 | M · Option Exercise | −100.00 | 0.9489 | — | 324.87K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock609.00 shares | 10/4/2022 | M · Option Exercise | −609.00 | 0.9489 | — | 324.26K |